Angharad G. Goodman
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Journal: JCO precision oncology
Published: July 16, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Journal: JCO precision oncology
Published: July 01, 2026
Integrated clinical, genomic and functional characterization of a novel ALK variant in neuroblastoma.
Journal: Cancer letters
Published: November 05, 2025
Detection of GD2 negative circulating tumour cells in neuroblastoma by machine learning.
Journal: Cancer letters
Published: October 07, 2025
Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA.
Journal: International journal of molecular sciences
Published: August 12, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.
Journal: The Journal of molecular diagnostics : JMD
Published: April 08, 2025
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three-fold volume increase without life- or organ-threatening features.
Journal: Pediatric blood & cancer
Published: March 09, 2024
Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Journal: Cancers
Published: September 25, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 29, 2022
Loss of ALK hotspot mutations in relapsed neuroblastoma.
Journal: Genes, chromosomes & cancer
Published: January 06, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026